Healthcare Industry News:  V.A.C. 

Devices Wound Care Product Launch

 News Release - August 14, 2007

KCI Announces Early Success in Global Launch of Next Generation InfoV.A.C.(R) Therapy System

SAN ANTONIO--(HSMN NewsFeed)--Kinetic Concepts, Inc. (NYSE:KCI ), a leading global advanced wound care and therapeutic surfaces company, today announced initial favorable results from customer placements of its next generation V.A.C.® Therapy System - InfoV.A.C.® As a part of the launch process, customers evaluated the therapy's enhanced capabilities, which include intuitive, easy-to-use operating features designed to simplify training and improve patient compliance. Caregiver response has been favorable, and the new system received high ratings in post-launch customer surveys.

KCI's new InfoV.A.C.® Therapy System enhancements were based largely on "Voice of the Customer" input from patients and caregivers. "Time is critical for patients and nurses, and the Seal Check(TM) feature saves time in trying to achieve a seal," said Sue Mendez-Eastman, RN, Certified Wound Nurse and a key opinion leader in the area of advanced wound care. "The Digital Wound Image Analysis feature helps in the documentation of wound healing and facilitates the dissemination of wound information among multi-disciplinary teams. Also, InfoV.A.C.®'s compact design works really well in a patient room that is already cluttered with so much equipment," Mendez-Eastman added.

"V.A.C.® Therapy continues to be accepted as an excellent option for the treatment of complex and even life-threatening wounds," said Catherine M. Burzik, President and Chief Executive Officer of KCI. "By improving patient compliance and ensuring optimal delivery of NPWT, the InfoV.A.C.® Therapy System will improve upon the already outstanding outcomes for which V.A.C.® Therapy is recognized globally."

V.A.C.® Therapy's clinical benefits and economic value are supported by an extensive body of medical evidence including 14 randomized controlled trials, more than 350 peer-reviewed publications and references in more than 50 medical text books. Most recently, KCI announced the results of the largest randomized controlled trial on the use of V.A.C.® Therapy in the treatment of the diabetic foot. The study involved 335 patients across 37 participating centers and demonstrated that V.A.C.® Therapy significantly increased the number of wounds achieving complete closure as well as a reduction in the time required to achieve wound healing. Since its introduction, V.A.C.® Therapy has treated approximately 2 million patients with more than 23 million therapy-days. It is the only NPWT offering specifically cleared by the FDA for all care settings, including the home.

About KCI

Kinetic Concepts, Inc. is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care. Our advanced wound-care systems incorporate our proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy technology, which has been demonstrated clinically to help promote wound healing through unique mechanisms of action and can help reduce the cost of treating patients with serious wounds. Our therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address pulmonary complications associated with immobility, to prevent skin breakdown and assist caregivers in the safe and dignified handling of obese patients. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings, including acute care hospitals, extended care organizations and patients' homes, both in the United States and abroad.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the clinical evidence relating to V.A.C.® Therapy and the potential impact of the launch of the InfoV.A.C.® Therapy System and customer preference. These forward-looking statements are based on our current expectations and are subject to a number of risks and uncertainties. All information set forth in this release is as of its date, and we undertake no duty to update this information. More information about the company is described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006 and our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2007, on file with the SEC and available at the SEC's website at

Source: Kinetic Concepts

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.